PubRank

Dean E Dluzen

Author PubWeight™ 23.80‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Gender differences in Parkinson's disease. J Neurol Neurosurg Psychiatry 2006 2.23
2 Neuroprotective actions of sex steroids in Parkinson's disease. Front Neuroendocrinol 2009 1.37
3 Estrogen prevents neuroprotection by caffeine in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. J Neurosci 2006 1.03
4 Protective effects of ginsenoside Rg2 against glutamate-induced neurotoxicity in PC12 cells. J Ethnopharmacol 2006 1.01
5 Oestrogen and nigrostriatal dopaminergic neurodegeneration: animal models and clinical reports of Parkinson's disease. Clin Exp Pharmacol Physiol 2007 0.92
6 Dopamine transporter function differences between male and female CD-1 mice. Brain Res 2005 0.88
7 Methamphetamine-induced loss of striatal dopamine innervation in BDNF heterozygote mice does not further reduce D3 receptor concentrations. Synapse 2004 0.88
8 Sex differences in methamphetamine toxicity in mice: effect on brain dopamine signaling pathways. Psychoneuroendocrinology 2011 0.87
9 Sex differences in striatal dopaminergic function within heterozygous mutant dopamine transporter knock-out mice. J Neural Transm (Vienna) 2008 0.85
10 Signaling pathways mediating the neuroprotective effects of sex steroids and SERMs in Parkinson's disease. Front Neuroendocrinol 2012 0.83
11 Genetic alteration in the dopamine transporter differentially affects male and female nigrostriatal transporter systems. Biochem Pharmacol 2009 0.82
12 Structure-activity relationship and docking studies of thiazolidinedione-type compounds with monoamine oxidase B. Bioorg Med Chem Lett 2011 0.81
13 Methyl Yellow: A Potential Drug Scaffold for Parkinson's Disease. Chembiochem 2014 0.81
14 Dose-response effects of estrogen and tamoxifen upon methamphetamine-induced behavioral responses and neurotoxicity of the nigrostriatal dopaminergic system in female mice. Neuroendocrinology 2004 0.80
15 Testosterone enhances dopamine depletion by methamphetamine in male, but not female, mice. Neurosci Lett 2008 0.80
16 Nomifensine alters sex differences in striatal dopaminergic function. Synapse 2012 0.80
17 Sex and temporally-dependent effects of methamphetamine toxicity on dopamine markers and signaling pathways. Neuropharmacology 2012 0.79
18 Testosterone modulation of striatal dopamine output in orchidectomized mice. Synapse 2006 0.78
19 Differential protective properties of estradiol and tamoxifen against methamphetamine-induced nigrostriatal dopaminergic toxicity in mice. Neuroendocrinology 2006 0.78
20 Effect of estrogen upon methamphetamine-induced neurotoxicity within the impaired nigrostriatal dopaminergic system. Synapse 2006 0.78
21 Rotenone produces opposite effects upon mouse striatal dopamine function as a result of environmental temperature. Neurotox Res 2006 0.77
22 Estrogen and Parkinson's disease. Adv Neurol 2003 0.76
23 Dopamine transporter as a marker of neuroprotection in methamphetamine-lesioned mice treated acutely with estradiol. Neuroendocrinology 2004 0.76
24 Markers associated with testosterone enhancement of methamphetamine-induced striatal dopaminergic neurotoxicity. Neurotoxicol Teratol 2012 0.76
25 Tamoxifen protects male mice nigrostriatal dopamine against methamphetamine-induced toxicity. Biochem Pharmacol 2007 0.76
26 Male/Female differences in neuroprotection and neuromodulation of brain dopamine. Front Endocrinol (Lausanne) 2011 0.76
27 Dimebon attenuates methamphetamine, but not MPTP, striatal dopamine depletion. Neurochem Int 2012 0.76
28 Sex differences in methamphetamine-evoked striatal dopamine of mice are reversed by nomifensine. Neurotoxicol Teratol 2006 0.75
29 Tamoxifen increases methamphetamine-evoked dopamine output from superfused striatal tissue fragments of male mice. Brain Res 2004 0.75
30 Effects of estrogen and related agents upon methamphetamine-induced neurotoxicity within an impaired nigrostriatal dopaminergic system of ovariectomized mice. Neuroendocrinology 2006 0.75
31 Effects of a novel dopamine uptake inhibitor upon extracellular dopamine from superfused murine striatal tissue. Eur J Pharmacol 2009 0.75
32 Castration increases nisoxetine-evoked norepinephrine levels in vivo within the olfactory bulb of male rats. Neurosci Lett 2002 0.75